Premium
Letter: number of treatments with anti‐TNF‐α and reoperations in inflammatory bowel disease
Author(s) -
Nørgård B. M.,
Nielsen J.,
Kjeldsen J.,
Qvist N.
Publication year - 2013
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.12296
Subject(s) - medicine , infliximab , adverse effect , ulcerative colitis , surgery , inflammatory bowel disease , tumor necrosis factor alpha , crohn's disease , adalimumab , disease , colitis , gastroenterology